5 years treating AML
Dr. Tanaka is a translational researcher who focuses on the development of early-phase trials that offer new cancer treatments for patients. Her research work includes the study of epigenetic and genetic biomarkers in myelodysplastic syndromes (bone marrow disorders in which the bone marrow does not produce enough healthy blood cells), with the aim of translating these into clinical therapies to improve patient care.
Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.
Terms of Use and Privacy Policy Newsroom About Donations Find an AML Specialist Newsletter Learn Connect
Copyright © 2022 HealthTree Foundation. All Rights Reserved.
The HealthTree Foundation / HealthTree for AML is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811